Related scientific articles (all)

Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patient

Authors : Diamand R, Albisinni S
Year : 2022
Journal : Eur Urol Focus

Is pudendal nerve entrapment a potential cause for weak ejaculation?

Authors : Aoun F, Mjaess G, Lilly E, Khalil N, Tayeh GA, Sarkis J, Mansour R, Alkassis M, Chebel R, Absil F, Bollens R
Year : 2022
Journal : Int J Impot Res
Volume : 34
Pages : 520-523

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.

Authors : Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Martin R, Roumeguère T, Peltier A, Diamand R
Year : 2022
Journal : Prostate Cancer Prostatic Dis

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.

Authors : Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G
Year : 2022
Journal : Eur Urol Oncol

Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

Authors : Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Van Den Bergh RC, Peltier A, Ploussard G
Year : 2022
Journal : Minerva Urol Nephrol

Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens.

Authors : Rahota RG, Diamand R, Malavaud B, Fiard G, Descotes JL, Peltier A, Beauval JB, Roumeguère T, Roumiguié M, Albisinni S, Ploussard G
Year : 2022
Journal : BJU Int
Volume : 129
Pages : 621-626

Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature.

Authors : Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T
Year : 2022
Journal : Cancer
Volume : 128
Pages : 14-19

Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systém

Authors : Diamand R, Mjaess G, Ploussard G, Fiard G, Oderda M, Lefebvre Y, Sirtaine N, Roumeguère T, Peltier A, Albisinni S
Year : 2022
Journal : Prog Urol
Volume : 32
Pages : 6S3-6S18

Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.

Authors : Albisinni S, Diamand R, Mjaess G, Assenmacher G, Assenmacher C, Loos S, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Di Maida F, Minervini A, Aoun F, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T
Year : 2022
Journal : Urol Oncol
Volume : 40
Pages : 163.e11-163.e17

Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery.

Authors : Soria F, Pradere B, Hurle R, DAndrea D, Albisinni S, Diamand R, Laukhtina E, Di Trapani E, Aziz A, Krajewski W, Teoh JY, Mari A, Moschini M, Chiancone F, Autorino R, Porreca A, Marchioni M, Liguori G, Lucarelli G, Busetto GM, Foschi N, Antonelli A, Bove P, Russo GI, Crisan N, Borghesi M, Boeri L, Veccia A, Greco F, Longo N, De Cobelli O, Shariat SF, Gontero P, Ferro M
Year : 2022
Journal : Eur Urol Open Sci
Volume : 42
Pages : 1-8

(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Authors : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Year : 2022
Journal : J Nucl Med
Volume : 63
Pages : 1191-1198

Anterior vs. Retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference?

Authors : Albisinni S, Dasnoy C, Diamand R, Mjaess G, Aoun F, Esperto F, Porpiglia F, Fiori C, Roumeguere T, DE Nunzio C
Year : 2022
Journal : Minerva Urol Nephrol
Volume : 74
Pages : 137-145

Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature.

Authors : Karam A, Mjaess G, Albisinni S, El Daccache Y, Farah M, Daou S, Kazzi H, Hassoun R, Bou Kheir G, Aoun F, Roumeguère T
Year : 2022
Journal : World J Urol
Volume : 40
Pages : 951-964

Une nouvelle thérapie focale pour les patients atteints d’un cancer localisé de la prostate : l’ablation par micro-ondes guidée par fusion élastique IRM-Échographie 3D (Organ-Based Tacking Fusion®) - Résultats préliminaires d’une étude d’ablation et

Authors : Peltier A, Assenmacher G, Diamand R, Hawaux E, Limani K, Sirtaine N, Ben Aziz M, Lefebvre Y, Lemort M, Roumeguère T, Van Velthoven R
Year : 2021
Journal : Prog Urol
Volume : 31(13)
Pages : 881-882

Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications.

Authors : Diamand R, Ploussard G, Roumiguié M, Malavaud B, Oderda M, Gontero P, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Peltier A, Simone G, Roche JB, Roumeguère T, Albisinni S
Year : 2021
Journal : Urol Oncol
Volume : 39
Pages : 296.e1-296.e9

Le rôle des biopsies péri-lésionnelles associées aux biopsies ciblées IRM/échographie pour améliorer la concordance histopathologique entre biopsie et prostatectomie radicale

Authors : Hollans M, Diamand R, Lefebvre Y, Sirtaine N, Abou Zahr R, Mattlet A, Limani K, Hawaux E, Roumeguère T, Albisinni S, Peltier A
Year : 2021
Journal : Prog Urol
Volume : 31(13)
Pages : 791-792

Does antibiotic use explain the discrepancy of urolithiasis prevalence between countries?

Authors : Karam A, Mjaess G, Aoun F, Albisinni S, Vafa H, Roumeguere T
Year : 2021
Journal : Urolithiasis
Volume : 49
Pages : 181-182

Pudendal nerve release for lower urinary tract symptoms in young males.

Authors : Aoun F, Mjaess G, Akl B, Nassar D, Kallas Chemaly A, Haydar A, Raad R, Absil F, Nemr E, Bollens R
Year : 2021
Journal : Low Urin Tract Symptoms
Volume : 13
Pages : 286-290

Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.

Authors : Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Peltier A, Simone G, van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Quackels T, Roumeguère T, Albisinni S
Year : 2021
Journal : World J Urol
Volume : 39
Pages : 1789-1796

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.

Authors : Marra G, Karnes RJ, Calleris G, Oderda M, Alessio P, Palazzetti A, Battaglia A, Pisano F, Munegato S, Munoz F, Filippini C, Ricardi U, Linares E, Sanchez-Salas R, Goonewardene S, Dasgupta P, Challacombe B, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Smelzo S, Piechaud T, Taille A, Roupret M, Albisinni S, Van Velthoven R, Morlacco A, Vidit S, Gandaglia G, Mottrie A, Smith J, Joshi S, Fiscus G, Berger A, Aron M, Abreu A, Gill IS, Van Der Poel H, Tilki D, Murphy D, Lawrentschuk N, Davis J, Gontero P
Year : 2021
Journal : Urol Oncol
Volume : 39
Pages : 296.e21-296.e29